Supplement: Therapeutic Cancer Vaccine Roundup
Individualized Cell Therapies Come with a Unique Set of Bioprocess Requirements
Supplement: Circumventing Cancer Cells’ Defenses
Cancer Cells Can Exploit Well-Evolved Moves to Evade Immune Detection
Smelly Camel Urine Finding Could Lead to Novel Therapies for Sleeping Sickness
Sounds of Science Podcast
Supplement: Treating “Solid” Tumors with CAR T Cells
The Road to Developing Effective Cancer Immunotherapies Using CAR T Cells Has Been a Long and Sometimes Rocky One
For full access to this article login to GEN Select now.
Exploiting Post-Translational Modifications
Assessing Strategies to Meet Demand
- By 2010, glycoprotein and antibody drugs are expected to exceed $68 billion in worldwide sales. Meeting the demand for such therapeutics is generating challenges for both production and manufacturing. Chief among these is accurately and reproducibly mimicking natural post-translational modifications. Identifying and characterizing such modifications impact half-life, quality, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.